View More 2024, Presenter Profiles

Presenter Profiles: Just Do It—Incorporating What We Know into What We Do

|

Estimated Read Time:

2 minutes


2024 Presenter Profiles

Just Do It—Incorporating What We Know into What We Do

Monday, June 24, at 1:30 p.m. ET
Room W315
Orange County Convention Center


EHR-Based Tools to Overcome Therapeutic Inertia and Improve Health Equity in Diabetes Technology Prescriptions

Brittany Bruggeman, MD
Brittany Bruggeman, MD

Brittany S. Bruggeman, MD

Assistant Professor of Pediatric Endocrinology,
University of Florida

What is your presentation about?
In previous research, diabetes provider-level barriers prevented underserved patients from adopting diabetes technologies (ie, CGMs and insulin pumps). In our research, we interviewed providers to hear from their perspective what prevents them from prescribing these technologies. Providers most commonly reported that bureaucratic and systematic barriers such as difficulty in determining insurance coverage, DME versus pharmacy benefits, and the cost of devices were prohibitive. They supported the idea of a Diabetes Technology Dashboard within the electronic health record (EHR), in which they would receive prescription performance feedback and have clinical decision support tools to aid in diabetes technology prescriptions.

How do you hope your presentation will impact diabetes research or care?
Diabetes providers are stretched thin and face many bureaucratic barriers to overcoming therapeutic inertia, even when they know that a new therapy is in a patient’s best interest. We hope that our research will demonstrate the systematic barriers that providers face in prescribing diabetes technologies and will promote pragmatic solutions.

How did you become involved with this area of diabetes research or care?
As a pediatric endocrinologist, I see every day how CGMs and insulin pumps help my patients to lower the burden of diabetes management in their day to day lives. However, I also see the many barriers that patients and providers face in accessing these technologies. I became involved in this research to try to address some of these multi-level barriers.


The Michigan Collaborative for Type 2 Diabetes

Lauren Oshman, MD, MPH, FAAFP, Diplomate ABOM
Lauren Oshman, MD, MPH, FAAFP, Diplomate ABOM

Lauren Oshman, MD, MPH, FAAFP, Diplomate ABOM

Associate Professor of Family Medicine,
University of Michigan Medical School

What is your presentation about?
Is it possible to coordinate more than 300 primary care and specialty care practices from different health systems across the state of Michigan to improve quality for type 2 diabetes? By listening to the needs of clinicians and their patients and using trusted data and user-centered design and creative QI efforts, we are doing just that at the Michigan Collaborative for Type 2 Diabetes.

How do you hope your presentation will impact diabetes research or care?
We’ll share how we structure and function to improve diabetes care, some challenges we’ve solved, and our hopes for the future.

How did you become involved with this area of diabetes research or care?
The Michigan Collaborative for Type 2 Diabetes was founded in 2020.

Register Today for the 84th Scientific Sessions


Join us in Orlando for the 84th Scientific Sessions, June 21-24. Full in-person registration includes access to all of the valuable onsite content during the meeting and on-demand access to the virtual program June 25-Aug. 26. For those unable to join us in-person, we are planning a virtual program to allow as many people as possible to participate and learn about the latest advances in diabetes research, prevention, and care.